Lab Med Online.
2022 Oct;12(4):235-243. 10.47429/lmo.2022.12.4.235.
Clinical Application of Circulating Tumor DNA Analysis
- Affiliations
-
- 1Department of Laboratory Medicine, Yonsei University College of Medicine, Seoul, Korea
- KMID: 2538611
- DOI: http://doi.org/10.47429/lmo.2022.12.4.235
Abstract
- Liquid biopsy using circulating tumor DNA helps overcome the limitations of conventional tissue testing. Non-invasive molecular profiling using circulating tumor DNA is increasingly being used to diagnose cancer, stratify risk, and select targeted treatments. By understanding the biological characteristics of circulating tumor DNA and patient factors that can affect concentrations of circulating tumor DNA as well as optimizing the techniques, the clinical utilization of circulating tumor DNA tests can be improved. It is also necessary to formulate guidelines for the administration and reporting of circulating tumor DNA tests.
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Clinical Circulating Tumor DNA Testing for Precision Oncology
- Current Methods of Circulating Tumor Cell Detection
- Circulating Tumor Cell and Cell-free Circulating Tumor DNA in Lung Cancer
- Exploring the prognostic value of ultra-low-pass whole-genome sequencing of circulating tumor DNA in hepatocellular carcinoma
- Circulating Tumor Cells: Detection Methods and Potential Clinical Application in Breast Cancer
